However, because of complications associated with radiotherapy and the less favorable vision outcome, ophthalmologists seek other treatment options for CCH and start to use anti-vascular endothelial growth factor (anti-VEGF) agents to treat CCH and concomitant exudative retinal detachment. This evidence concerns the gene VEGFA and columnar cell hyperplasia of the breast.